Which type of hypersensitivity reaction is associated with systemic lupus erythematosus (SLE)?

Which type of hypersensitivity reaction is associated with systemic lupus erythematosus (SLE)?

• A. Type I
• B. Type II
• C. Type III
• D. Type IV

Answer: (C)

Systemic lupus erythematosus (SLE) is primarily associated with Type III hypersensitivity reactions. This type of hypersensitivity involves the formation of immune complexes that consist of antibodies bound to soluble antigens. In SLE, the body produces antibodies against its own nuclear components, such as DNA, leading to the formation of immune complexes that can deposit in various tissues including the kidneys, skin, and joints. As these immune complexes accumulate, they trigger an inflammatory response, causing damage to the tissues involved. The resultant inflammation and tissue damage are characteristic of the manifestations observed in SLE, such as arthritis, skin rashes, and nephritis. This understanding of Type III hypersensitivity is crucial, as it clarifies how the immune system's misguided response in SLE contributes to the clinical symptoms and complications associated with the disease. Knowledge of the underlying mechanisms helps inform therapeutic approaches targeting the pathological processes at play in SLE.

Systemic lupus erythematosus (SLE) is primarily associated with Type III hypersensitivity reactions. This type of hypersensitivity involves the formation of immune complexes that consist of antibodies bound to soluble antigens. In SLE, the body produces antibodies against its own nuclear components, such as DNA, leading to the formation of immune complexes that can deposit in various tissues including the kidneys, skin, and joints.

As these immune complexes accumulate, they trigger an inflammatory response, causing damage to the tissues involved. The resultant inflammation and tissue damage are characteristic of the manifestations observed in SLE, such as arthritis, skin rashes, and nephritis.

This understanding of Type III hypersensitivity is crucial, as it clarifies how the immune system's misguided response in SLE contributes to the clinical symptoms and complications associated with the disease. Knowledge of the underlying mechanisms helps inform therapeutic approaches targeting the pathological processes at play in SLE.